RxDoctor Payments Data

Kevin Anton

Vascular & Interventional Radiology · Philadelphia, PANPI 1609134519

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,219 of the $13,693 with a category attached, or 67.3%. 20 manufacturers reported payments, led by Canon Medical Systems USA, Inc. at 32.1% of the total. Reporting peaked in 2019 at $4,988 and has fallen 93.8% since, to $307 in 2025.

$13,693in general payments, 2019–2025

Across 91 payments — averaging $150.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Canon Medical Systems USA, Inc.$4K
  • Biocompatibles, Inc.$4K
  • Inari Medical, Inc.$1K
  • Terumo Medical Corporation$717
  • Boston Scientific$656
  • Argon Medical Devices, Inc.$519
  • plus $2K from 14 others
$339,773in research payments, 2019–2025

Across 69 payments — averaging $4924.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ethicon Endo-surgery Inc.$247K
  • Lantheus Medical Imaging, Inc.$52K
  • AstraZeneca$40K
  • Bracco Diagnostics Inc.$574

What the payments were for

  • Consulting fees$9,21967%
  • Travel & lodging$2522%
  • Food & beverage$4,09730%
  • Entertainment$1251%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,693 in reported general payments places this provider in the 85th percentile of 223 vascular & interventional radiology providers in Pennsylvania.

See all vascular & interventional radiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$84,533
Medicare patients
189
Services billed
702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →